MORGAN STANLEY - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,380,045
-33.8%
1,381,718
+3.8%
0.00%
-100.0%
Q2 2023$6,617,242
+36.5%
1,331,437
+35.7%
0.00%0.0%
Q1 2023$4,848,488
-9.4%
981,475
+15.4%
0.00%0.0%
Q4 2022$5,349,513
-19.6%
850,479
+38.1%
0.00%0.0%
Q3 2022$6,653,000
-48.7%
616,019
-45.8%
0.00%
-50.0%
Q2 2022$12,964,000
-15.7%
1,137,265
-32.6%
0.00%0.0%
Q1 2022$15,380,000
-18.6%
1,688,441
+33.4%
0.00%0.0%
Q4 2021$18,890,000
-30.9%
1,266,055
+19.1%
0.00%
-50.0%
Q3 2021$27,319,000
-7.3%
1,063,026
-5.9%
0.00%0.0%
Q2 2021$29,456,000
+792.1%
1,129,478
+1107.0%
0.00%
Q1 2021$3,302,000
-61.8%
93,580
-72.7%
0.00%
-100.0%
Q4 2020$8,651,000
+14.5%
342,782
+71.0%
0.00%0.0%
Q3 2020$7,558,000
+275.1%
200,415
+325.8%
0.00%
Q2 2020$2,015,000
+119.0%
47,070
-0.5%
0.00%
Q1 2020$920,000
-55.9%
47,329
-41.0%
0.00%
Q4 2019$2,084,000
+141.2%
80,166
+153.1%
0.00%
Q3 2019$864,000
+232.3%
31,674
+226.3%
0.00%
Q2 2019$260,0000.0%9,707
+7.7%
0.00%
Q1 2019$260,000
-73.7%
9,016
-75.5%
0.00%
Q4 2018$990,00036,7310.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders